H3M4/ Flashcards
1
Q
- Part of the vascular intima that is involve in clotting process by
producing and storing clotting components
a. CT Matrix
b. Endothelium
c. Subendothelial Collagen
d. Subendothelial CT
A
b. Endothelium
2
Q
- Procoagulant property of a damaged vascular intima which
binds vWF that binds and activates platelets
a. An exposed smooth muscle cells & fibroblast
b. An exposed subendothelial collagen
c. Damaged or activated endothelial cells that secretes vWF
d. Smooth muscles found in arterioles & arteries
A
b. An exposed subendothelial collagen
3
Q
- Properties of platelet wherein platelet binds to a non-platelet
surface:
a. Adhesion
b. Aggregation
c. Secretion
A
a. Adhesion
4
Q
- The narrowing of the lumen of the blood vessels during primary
hemostasis will:
a. Decrease the blood flow on the uninjured area of blood vessels
b. Increase the blood flow on the injured area of blood vessels
c. Release of circulating inhibitors in the plasma
d. Release of clotting properties of the endothelium
e. None
A
e. None
5
Q
- The conversion of membrane phospholipids to arachidonic acid
during platelet secretion is the function of
a. Cyclooxygenase
b. Phospholipid A2
c. Thromboxane A2
d. Thromboxane Synthetase
e. NONE (Phospholipase A2 dapat)
A
e. NONE (Phospholipase A2 dapat)
6
Q
- The conversion of arachidonic acid to prostaglandin
endoperoxidase during platelet secretion is the function of:
(Choices from Q5)
a. Cyclooxygenase
b. Phospholipid A2
c. Thromboxane A2
d. Thromboxane Synthetase
A
a. Cyclooxygenase
7
Q
- A form of hereditary vascular disorder that has a vascular defect
wherein the blood vessels are thin-walled with a discontinuous
endothelium, inadequate smooth muscle, and inadequate or
missing elastin in the surrounding stroma:
a. Ehlers-Danlos Syndrome
b. Louis-Bar Syndrome
c. Kasabach-Merritt Syndrome
d. Rendu-Osler-Weber Syndrome
A
d. Rendu-Osler-Weber Syndrome
8
Q
- A form of hereditary vascular disorder that has a vascular defect
in collagen production, structure, or crosslinking, with resulting
inadequacy of the connective issues: (Choices from Q7)
a. Ehlers-Danlos Syndrome
b. Louis-Bar Syndrome
c. Kasabach-Merritt Syndrome
d. Rendu-Osler-Weber Syndrome
A
a. Ehlers-Danlos Syndrome
9
Q
- A form of hereditary vascular disorder which involves association of a giant cavernous hemangioma (vascular tumor),
thrombocytopenia, and a bleeding diathesis: (Choices from Q#7)
a. Ehlers-Danlos Syndrome
b. Louis-Bar Syndrome
c. Kasabach-Merritt Syndrome
d. Rendu-Osler-Weber Syndrome
A
c. Kasabach-Merritt Syndrome
10
Q
- The following are acquired defects of platelet adhesion,
except:
a. Anli-platelet antibodies
b. Chronic Liver Disease
c. Scott Syndrome
d. All of These
A
c. Scott Syndrome
11
Q
- An autosomal recessive thrombocytopenias which involves
mutations in the NBLEA2 Gene:
a. Congenital Amegakaryocytic Thrombocytopenia
b. Immune Thrombocytopenia
c. Gray Platelet Syndrome
d. Wiskott-Aldrich Syndrome
e. NONE (NBEAL2 Gene dapat) if typo → GPS
A
c. Gray Platelet Syndrome
12
Q
- An even in the physiologic hemostasis wherein there is a
gradual digestion and removal of the fibrin clot as healing of the
injury occurs:
a. Coagulation
b. Fibrinolysis
c. Platelet Secretion
d. Vasoconstriction
A
b. Fibrinolysis
13
Q
- It is exposed from a disrupted subendothelial cells which
activates the coagulation system through contact with plasma
Factor VIl
a. Collagen
b. Tissue Factor
c. ТРА
d. Thrombomodulin
A
b. Tissue Factor
14
Q
- It binds to GP IIb/IIIa receptors on adjacent platelets and joins
them together in the presence of an ionized calcium.
a. Fibrillin
b. Fibrin
c. Fibrinogen
d. Fibronectin
A
c. Fibrinogen
15
Q
- The following coagulation factors are consumed during the
process of coagulation except:
a. Antihemophilic Factor A
b. Fibrin Stabilizing Factor
c. Proaccelerin
d. Proconvertin
A
d. Proconvertin
16
Q
- The following are calcium and vitamin k independent
coagulation factors, except:
a. Fitzgerald Factor
b. Fletcher Factor
c. PTA
d. PTC
A
d. PTC
17
Q
- The primary in vivo initiation mechanism for extrinsic
coagulation cascade depends on the formation of a.
a. IXa: VIlla
b. TF.Via
c. TF:VIla
d. Xa:Va
A
c. TF:VIla
18
Q
- It is considered the marker of thrombosis and fibrinolysis:
a. Fragment D-E-D
b. Fragment E
c. Fragment X
d. Fragment Y
e. None (D-Dimer)
A
e. None (D-Dimer)
19
Q
- An intrinsic plasminogen activator secreted by the urinary tract
epithelial cells, monocles and macrophages that convert
plasminogen into its activated for:
a. PAl-1
b. TAFI
c. ТРА
d. UPA
A
d. UPA
20
Q
- It is considered the primary inhibitor of free plasmin:
a. A2-antiplasminogen
b. PAI-1
c. TAFI
d. TFPI
E. none A2 antiplasmin
A
E. none A2 antiplasmin
21
Q
- The internal elastic lamina which primarily supports the
endothelial cells are composed of
a. Collagen & Elastin
b. Collagen & Fibroblasts
c. Elastin & Proteases
d. Elastin & Zymogens
A
a. Collagen & Elastin
22
Q
- Bernard-Soulier Syndrome involves an abnormal platelet
function due to this missing platelet membrane receptor:
a. GPIb/Ila Receptor
b. GPIb/Ila Receptor
c. GPIII Receptor
d. GPIla/lIb Receptor
e. none
A
e. none
23
Q
- Glanzmann Thrombasthenia involves an abnormal platelet
function due to this missing platelet membrane receptor: (Choices
from Q#22)
a. GPIb/Ila Receptor
b. GPIb/Ila Receptor
c. GPIII Receptor
d. GPIla/lIb Receptor
e. none
A
e. none
24
Q
- The following are components of the platelet alpha-granules,
except:
a. ATP
b. PDGF
c. Protein S
d. B-Thromboglobulin
A
a. ATP
25
Q
- FVI was removed & never reassigned as part of the blood
clotting factors because:
a. It was determined to an activated form of contact factor
b. It was determined to be an activated form of proconvertin
c. It was determined to be an activated form of proaccelerin
d. It was determined to be an activated form of stable factor
A
c. It was determined to be an activated form of proaccelerin
26
Q
- Coagulation factors that are affected by coumadin (PIVKAS):
a. Prothrombin, Proaccelerin, PTA, Stuart Factor
b. Prothrombin, Proaccelerin, PTC, Stuart Factor
c. Prothrombin, Proconvertin, PTA, Stuart Factor
d. Prothrombin, Proconvertin, PTC, Stuart Factor
A
d. Prothrombin, Proconvertin, PTC, Stuart Factor
27
Q
- Initiation phase of the coagulation cascade will produce
________ of the total thrombin generated:
a. 2-3%
b. 3-5%
c. >95%
d. >99%
A
b. 3-5%
28
Q
- It is a cofactor to FVIla:
a. Contact Factor
b. Fletcher Factor
c. Labile Factor
d. Stable Factor
e. none
A
e. none
29
Q
- TF:FVIla complex will activate low levels of:
a. Christmas & Stuart Factor
b. Labile & Stable Factor
c. Proconverlin & Proaccelerin
d. PTA & PTC
A
a. Christmas & Stuart Factor
30
Q
- These are activated by thrombin in the initiation phase bind to
platelet membranes and become receptors for FX and FIXa:
a. Flla & FVa
b. FVa & FVIla
c. FVa & FVIlla
d. FXa & FVa
A
c. FVa & FVIlla
31
Q
- A rare autosomal recessive disorder characterized by a specific
absence of morphologically recognizable alpha-granules in
platelets.
a. Chediak-Higashi Syndrome
b. TAR Syndrome
c. Hermansky Pudlak Syndrome
d. Wiskott-Aldrich Syndrome
e. none
A
e. none
32
Q
- An autosomal recessive disorder with a defective lysosomal
function in variety of cells types with a tyrosine positive
oculocutaneous albinism and a profound platelet dense granule
deficiency. (Choices from Q#32)
a. Chediak-Higashi Syndrome
b. TAR Syndrome
c. Hermansky Pudlak Syndrome
d. Wiskott-Aldrich Syndrome
A
c. Hermansky Pudlak Syndrome